You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

denosumab

( den-OH-sue-mab )
Funding:
Exceptional Access Program
  • denosumab - Bony metastases in hormone refractory prostate cancer, with specific criteria
New Drug Funding Program
  • Denosumab - Hormone Refractory Prostate Cancer
Other Name(s): Xgeva® ()
Appearance: clear, colourless to slightly yellowish solution

Patient Info Sheet

Jul 2018

What it is used for

Denosumab may:

  • Help relieve bone pain and prevent broken bones in some types of cancer that arise from or spread to the bones
  • Be used to treat giant cell tumour of bone in some patients
  • Be used to remove excess calcium in the blood that is a problem with some types of cancer, if other treatments have not worked


You might also be interested in